170 related articles for article (PubMed ID: 16317099)
1. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy.
Ni H; Chen P; Spring CM; Sayeh E; Semple JW; Lazarus AH; Hynes RO; Freedman J
Blood; 2006 Apr; 107(7):2976-83. PubMed ID: 16317099
[TBL] [Abstract][Full Text] [Related]
2. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.
Chen P; Li C; Lang S; Zhu G; Reheman A; Spring CM; Freedman J; Ni H
Blood; 2010 Nov; 116(18):3660-8. PubMed ID: 20647570
[TBL] [Abstract][Full Text] [Related]
3. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
[TBL] [Abstract][Full Text] [Related]
4. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
5. The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.
Li C; Piran S; Chen P; Lang S; Zarpellon A; Jin JW; Zhu G; Reheman A; van der Wal DE; Simpson EK; Ni R; Gross PL; Ware J; Ruggeri ZM; Freedman J; Ni H
J Clin Invest; 2011 Nov; 121(11):4537-47. PubMed ID: 22019589
[TBL] [Abstract][Full Text] [Related]
6. Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia.
Li C; Chen P; Vadasz B; Ma L; Zhou H; Lang S; Freedman J; Ni H
Thromb Haemost; 2013 Dec; 110(6):1250-8. PubMed ID: 24067944
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization.
Mandelbaum M; Koren D; Eichelberger B; Auerbach L; Panzer S
Vox Sang; 2005 Jul; 89(1):39-43. PubMed ID: 15938738
[TBL] [Abstract][Full Text] [Related]
8. Severe neonatal alloimmune thrombocytopenia caused by maternal sensitization against a new low-frequency alloantigen (Dom
Sullivan MJ; Kuhlmann R; Peterson JA; Curtis BR
Transfusion; 2017 Jul; 57(7):1847-1848. PubMed ID: 28518345
[No Abstract] [Full Text] [Related]
9. Fetal and neonatal alloimmune thrombocytopenia.
Zdravic D; Yougbare I; Vadasz B; Li C; Marshall AH; Chen P; Kjeldsen-Kragh J; Ni H
Semin Fetal Neonatal Med; 2016 Feb; 21(1):19-27. PubMed ID: 26810319
[TBL] [Abstract][Full Text] [Related]
10. Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia.
Aslam R; Hu Y; Gebremeskel S; Segel GB; Speck ER; Guo L; Kim M; Ni H; Freedman J; Semple JW
Blood; 2012 Sep; 120(10):2127-32. PubMed ID: 22760780
[TBL] [Abstract][Full Text] [Related]
11. Direct fetal administration of immunoglobulins: another disappointing therapy in alloimmune thrombocytopenia.
Weiner E; Zosmer N; Bajoria R; Sepulveda W; Vaughan JI; Letsky EA; Fisk NM
Fetal Diagn Ther; 1994; 9(3):159-64. PubMed ID: 8060511
[TBL] [Abstract][Full Text] [Related]
12. A single-nucleotide polymorphism in the human ITGB3 gene is associated with the platelet-specific alloantigen Va (HPA-17bw) involved in fetal maternal alloimmune thrombocytopenia.
Stafford P; Garner SF; Rankin A; Kekomaki R; Watkins NA; Ouwehand WH
Transfusion; 2008 Jul; 48(7):1432-8. PubMed ID: 18484951
[TBL] [Abstract][Full Text] [Related]
13. Are maternal antiplatelet antibodies a prothrombotic condition leading to miscarriage?
Schmaier AH
J Clin Invest; 2011 Nov; 121(11):4241-3. PubMed ID: 22019585
[TBL] [Abstract][Full Text] [Related]
14. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy.
Kaplan C
Transfus Clin Biol; 2001 Jun; 8(3):311-4. PubMed ID: 11499984
[TBL] [Abstract][Full Text] [Related]
16. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
Rayment R; Brunskill SJ; Stanworth S; Soothill PW; Roberts DJ; Murphy MF
Cochrane Database Syst Rev; 2005 Jan; (1):CD004226. PubMed ID: 15674934
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia.
Guo L; Yang L; Speck ER; Aslam R; Kim M; McKenzie CG; Lazarus AH; Ni H; Hou M; Freedman J; Semple JW
Blood; 2014 Jan; 123(3):422-7. PubMed ID: 24258817
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage.
Kanhai HH; van den Akker ES; Walther FJ; Brand A
Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976
[TBL] [Abstract][Full Text] [Related]
19. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
Lin M; Xu X; Lee HL; Liang DC; Santoso S
Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
[TBL] [Abstract][Full Text] [Related]
20. Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
Smith B; Christodoulou L; Clargo A; Eddleston A; Greenslade K; Lightwood D; Shock A; Tyson K; Brennan FR
Int Immunopharmacol; 2019 Jan; 66():362-365. PubMed ID: 30529500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
